Accessing OTC (Over-the-counter) market data has traditionally meant working through slow, fragmented, and operationally heavy processes, particularly for quantitative teams, hedge funds and institutions that depend on deep historical datasets. With OTC market data now available natively on Snowflake, users can access one of the industry’s most comprehensive OTC data sets instantly, securely, and without the complexity of file transfers or manual data engineering.
Our Snowflake Marketplace launch brings trillions of rows of regulated, high‑fidelity market data together in a single cloud‑native environment, spanning interest rate derivatives, money markets, FX, energy and commodities. Delivered through a zero‑copy architecture, this model removes historic pain points such as SFTP (SSH File Transfer Protocol) distribution, data lag, infrastructure overhead and long onboarding timelines, enabling users to start analysing governed datasets within minutes.
This article highlights eight things to know about how Parameta data is delivered through Snowflake, and how this approach accelerates analytics workflows, enhances price discovery, strengthens risk management, and enables AI‑driven insights across the enterprise.
1. Data is delivered at truly global scale
Parameta Solutions manages over a trillion rows of OTC financial market data including interest rate swaps, options, FX (Foreign Exchange or Forex), money markets and energy and commodity instruments sourced from 2,800+ brokerage desks from Tullet Prebon and ICAP worldwide and other leading liquidity venues. At this scale, traditional file-based delivery simply doesn’t work. Snowflake provides the cloud native foundation needed to deliver this data reliably, securely, and at speed.
2. There are no files, exports, or manual data transfers
Accessing Parameta data via Snowflake means:
- No Excel files
- No SFTP deliveries
- No manual recombination or validation
Instead, customers get direct login access to live datasets, eliminating delays, errors, and operational overhead.
3. Data access that once took months now takes minutes
Historically, delivering large historical datasets could take weeks or even months. With Snowflake’s zerocopy, oneclick provisioning, customers can access terabytes of governed data almost instantly — dramatically improving onboarding and trial experiences.
4. Zero‑copy sharing keeps dataaccurateand up to date
Snowflake’s zero‑copy model means:
- Data is never duplicated.
- There is a sole source of truth.
- Customers always query the latest version.
This removes the risk of stale data, version mismatches, and redelivery cycles.
5. The data is built for sophisticated buy‑side users
Snowflake is especially well suited to hedge funds and quantitative teams who:
- Need deep historical datasets.
- Run proprietary analytics and models.
- Want full control over how data is queried.
- Require secure, auditable access.
Customers can work with Parameta data directly in their own Snowflake environment, using familiar tools and workflows.
6. Access is only the beginning — understanding is built in
Parameta enhances Snowflake data shares with embedded Python notebooks, providing:
- Pre‑built queries.
- Guided onboarding.
- Clear examples of common use cases.
Instead of being handed a raw database, users get context and guidance from day one, accelerating time to insight.
7. You can ask questions using natural language
Parameta is leveraging Snowflake Cortex to enable natural language interaction with data. This allows users to:
- Ask questions without writing SQL.
- Explore complex datasets more easily.
- Get answers in minutes, not weeks.
Internally, this has already reduced customer query response times by 80–95%, and this capability will extend directly to customers as Snowflake releases new features.
8. You can access free trials of OTC data on Snowflake marketplace
Parameta is among the first in financial services to use declarative sharing specifically for trials. This means:
- Instant access to live datasets.
- No bespoke onboarding work.
- Faster evaluation and experimentation.
You can request access to free trials here:
- Interest Rate Derivatives
- Interest Rate Volatility
- Money Markets
- Fixed Income
- Inflation Derivatives
- Equity Derivatives
- FX
- Oil
There are many other OTC markets. Search for Parameta Solutions on Snowflake Marketplace to see the full list asset classes available.
Parameta Solutions
Parameta Solutions is the data and analytics division of the TP ICAP Group and the exclusive provider of OTC market data from TP ICAP’s leading brokerage brands, including ICAP, Tullett Prebon and PVM.
We deliver high‑quality OTC market data, indices and analytics across interest rate swaps and options, money markets, FX, and energy and commodities—empowering financial professionals worldwide with trusted insights for the creation of trading strategies, price discovery, pre & post trade analytics, risk management and regulatory compliance.
Contact us for more information on our OTC data products or to request a data sample.
Disclaimer
© 2026 ICAP Information Services Limited (“IISL”). This communication is provided by ICAP Information Services Limited or a member of its group (“Parameta”) and all information contained in or attached hereto (the “Information”) is for information purposes only and is confidential. Access to the Information by anyone other than the intended recipient is unauthorised without Parameta’s prior written approval. The Information may not be not used or disclosed for any purpose without Parameta’s prior written approval, including without limitation, storing, copying, distributing, licensing, selling or displaying the Information, using the Information in an application or to create derived data of any kind, co-mingling the Information with any other data or using the data for any unlawful purpose of for any purpose that would cause it to become a benchmark under any law, regulation or guidance. The Information is not, and should not be construed as, a live price, an offer, bid, recommendation or solicitation in relation to any financial instrument or investment or to participate in any particular trading strategy or constituting financial or investment advice or a financial promotion. The Information does not constitute a public offer under any applicable legislation or an offer to sell or a solicitation of an offer to buy any securities. The Information is not to be relied upon for any purpose whatsoever and is provided “as is” without warranty of any kind, either expressly or by implication, including without limitation as to completeness, timeliness, accuracy, continuity, merchantability or fitness for any particular purpose. All representations and warranties are expressly disclaimed, to the fullest extent possible under applicable law. In no circumstances will Parameta be liable for any indirect or direct loss, or consequential loss or damages including without limitation, loss of business or profits arising from the use of, any inability to use, or any inaccuracy in the Information. Parameta may suspend, withdraw or modify or change the terms of the provision of the Information at any time in its sole discretion, without notice. All rights, including without limitation intellectual property rights, in and to the Information are, and shall remain, the property of IISL or its licensors. Use of, access to or delivery of Parameta’s products and/or services requires a prior written licence from Parameta or its relevant affiliates. The terms of this disclaimer are governed by the laws of England and Wales.
